8 Results for "

rat α4β2-nAChR

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "rat α4β2-nAChR" in MCE Product Catalog:

Cat. No.: HY-110160
CAS No.: 161416-61-1
Purity:  99.06%
Synonyms: ABT-089 dihydrochloride
Target:  

nAChR

Research Areas:  

Neurological Disease

Pozanicline dihydrochloride (ABT-089 dihydrochloride) is an orally bioavailable nicotinic acetylcholine receptor (nAChR) agonist with a Ki of 16.7 nM for binding to [ 3H]cytisine sites . Pozanicline is an α4β2-selective nAChR agonist, which binds to rat brain α4β2 nAChR with a Ki of 17 nM while binding to α7 nAChR is insignificant .
loading...
    loading...
Cat. No.: HY-107686
CAS No.: 1217837-17-6
Purity:  98.97%
Synonyms: 5-I A-85380 dihydrochloride
Target:  

nAChR

Research Areas:  

Neurological Disease

5-Iodo-A-85380 dihydrochloride is a selective ligand of nAChR. 5-Iodo-A-85380 dihydrochloride binds to α4β2 nAChRs in rat and human brain with Kds of 12 and 14 pM,respectively .
loading...
    loading...
Cat. No.: HY-138953
CAS No.: 188895-96-7
Target:  

nAChR

Research Areas:  

Neurological Disease

Epiboxidine is a potent and selective neural nAChR agonist with Kis of 0.46 nM and 1.2 nM for rat and human α4β2 nAChRs, respectively. Epiboxidine is a methylisoxazole analog of the alkaloid Epibatidine, and is also an analog of another nAChR agonist, ABT 418 .
loading...
    loading...
Cat. No.: HY-169742
CAS No.: 140111-52-0
Target:  

nAChR mAChR

Research Areas:  

Neurological Disease

Epibatidine is a nicotinic acetylcholine receptor (nAChR) agonist, with an IC50 of 70 pM, a Ki of 43 pM for rat nAChR, a Kd range of 1.5-60 nM for human α7 nAChR, a Kd of 15 nM for rat α4β2 nAChR, and a Kd of 0.5 μM for rat α3β4 nAChR. Epibatidine selectively activates central nAChRs and binds to muscarinic acetylcholine receptors (mAChR). It is used in research on pain, Alzheimer's disease, Parkinson's disease, and schizophrenia-related pain .
loading...
    loading...
Cat. No.: HY-14565
CAS No.: 161417-03-4
Synonyms: ABT-089
Target:  

nAChR

Research Areas:  

Neurological Disease

Pozanicline (ABT-089) selectively activate neuronal nicotinic acetylcholine receptor (nAChR) subtypes, is a novel cholinergic agent that is a partial agonist at α4β2* nAChRs (Ki=16 nM) and shows high selectivity for α6β2* and α4α5β2 nAChR subtypes, the binding affinity (Ki, rat) for Pozanicline to [ 3H] cytisine sites is 16.7 nM. Pozanicline reverses nicotine withdrawal-induced cognitive deficits, may be an effective component of novel therapeutic strategies for nicotine addiction .
loading...
    loading...
Cat. No.: HY-138953A
CAS No.: 862909-67-9
Target:  

nAChR

Research Areas:  

Neurological Disease

Epiboxidine hydrochloride is a potent and selective neural nAChR agonist with Kis of 0.46 nM and 1.2 nM for rat and human α4β2 nAChRs, respectively. Epiboxidine hydrochloride is a methylisoxazole analog of the alkaloid Epibatidine, and is also an analog of another nAChR agonist, ABT 418 .
loading...
    loading...
Cat. No.: HY-110160R
CAS No.: 161416-61-1
Synonyms: ABT-089 dihydrochloride (Standard)
Research Areas:  

Neurological Disease

Pozanicline dihydrochloride (Standard) is the analytical standard of Pozanicline (dihydrochloride) (HY-110160). This product is intended for research and analytical applications. Pozanicline dihydrochloride (ABT-089 dihydrochloride) is an orally bioavailable nicotinic acetylcholine receptor (nAChR) agonist with a Ki of 16.7 nM for binding to [3H]cytisine sites . Pozanicline is an α4β2-selective nAChR agonist, which binds to rat brain α4β2 nAChR with a Ki of 17 nM while binding to α7 nAChR is insignificant .
loading...
    loading...
Cat. No.: HY-183666
CAS No.: 223796-90-5
Research Areas:  

Neurological Disease

NS3956 is a blood-brain barrier-permeable human α4β2-nicotinic acetylcholine receptor (nAChR) agonist (Ki = 0.36 nM). NS3956 induces dopamine release, produces analgesic effects, modulates rotational behavior in 6-OHDA-lesioned rats, and potentiates the effects of SSRI/SNRI in the forced swim test in mice. NS3956 can be used in research related to depression, Parkinson's disease, and acute pain .
loading...
    loading...